DIRECT BIOLOGICS LLC

In News

AlloDirect Launches First Direct-to-Tissue-Bank Biologics Marketplace for Orthopedic Surgeons, ASCs, and Practices - Orthopedics This Week

Orthopedics This Week - Apr 24, 2026

Exosomes: Company Spotlights from "A" to "Z" - BioInformant

BioInformant - Feb 06, 2026

Biotech targeting chronic diseases raises $1.7M in stock sale - Stock Titan

Stock Titan - Dec 16, 2025

Acute Respiratory Distress Syndrome Clinical Trial Pipeline - GlobeNewswire

GlobeNewswire - Apr 09, 2026

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Rett Syndrome Pipeline Gains Momentum as 20+ Leading Pharma Companies Advance Novel Therapies Through Expanding Clinical Trials | DelveInsight - Barchart.com

Barchart.com - May 27, 2026

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - newswire.com

newswire.com - Jan 12, 2021

Bankruptcy Law And Charging Order Law Collide Again In Pettine - Forbes

Forbes - Nov 23, 2023

For Nascent Exosome Field, One Company’s Win Is Everyone’s Gain - Citeline News & Insights

Citeline News & Insights - Sep 30, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment